Public-registry trials using ALE.C04 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Study of ALE.C04 in Patients With Head and Neck Cancer | Alentis Therapeutics AG | Head and Neck Cancer | PHASE1 / PHASE2 | 22 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →